LGMN and columnar cell hyperplasia of the breast: Chai et al. found that the level of legumain, a lysosomal cysteine protease, was significantly increased in the hippocampus of mice with CCH, considering the abnormal upregulation of legumain in mediating synaptic plasticity impairment and neuroinflammation, targeting legumain might be a potential therapy for CCH.